KRAS and colorectal carcinoma: In PDAC, both isoforms are detectable, but their specific role has not yet been elucidated [52], although it may parallel that found in colorectal carcinoma, where KRAS4A has been associated to a suppressive and pro-apoptotic activity, while KRAS4B would play an anti-apoptotic effect [124].